Andremacon Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
1
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
Andremacon General Information
Description
Operator of a biotechnology firm intended to focus on the development of new therapies for cancer and neurodegenerative diseases. The company develops safe and effective therapies for cancer and other neurodegenerative diseases using scientific and technological research with a focus on therapies for brain tumors, therapeutic assistance for solid and hematological neoplasms, enabling healthcare sector to use new anti-cancer therapy for patients wellness.
Contact Information
Website
www.andremacon.comCorporate Office
- Viale Ortles 22/4
- 20139 Milan(Milan)
- Italy
Corporate Office
- Viale Ortles 22/4
- 20139 Milan(Milan)
- Italy
Andremacon Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | 01-Aug-2022 | Completed | Generating Revenue |
Andremacon Signals
Andremacon Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Fondazione Unimi | Accelerator/Incubator |
Andremacon FAQs
-
When was Andremacon founded?
Andremacon was founded in 2014.
-
Where is Andremacon headquartered?
Andremacon is headquartered in Milan, Italy.
-
What is the size of Andremacon?
Andremacon has 1 total employees.
-
What industry is Andremacon in?
Andremacon’s primary industry is Drug Discovery.
-
Is Andremacon a private or public company?
Andremacon is a Private company.
-
What is Andremacon’s current revenue?
The current revenue for Andremacon is .
-
Who are Andremacon’s investors?
Fondazione Unimi has invested in Andremacon.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process